Sutro Biopharma (STRO) Non-Current Assets (2017 - 2025)

Sutro Biopharma (STRO) has 9 years of Non-Current Assets data on file, last reported at $22.9 million in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Assets fell 47.82% year-over-year to $22.9 million; the trailing twelve-month figure through Dec 2025 stood at $115.2 million (down 37.51% YoY), and the FY2025 full-year result was $22.9 million, down 47.82% from the prior year.
• Non-Current Assets retreated to $22.9 million in Q4 2025, from $27.5 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $122.9 million in Q4 2021 to a low of $22.9 million in Q4 2025.
• A 5-year average of $58.1 million and a median of $51.7 million in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets soared 708.24% in 2021 and slumped 56.23% in 2022, its largest moves.
• Tracing STRO's Non-Current Assets over 5 years: stood at $122.9 million in 2021, then sank by 56.23% to $53.8 million in 2022, then declined by 8.55% to $49.2 million in 2023, then decreased by 10.77% to $43.9 million in 2024, then plunged by 47.82% to $22.9 million in 2025.
• Business Quant data shows STRO's Non-Current Assets at $22.9 million in Q4 2025, $27.5 million in Q3 2025, and $30.7 million in Q2 2025.